Exchange: NASDAQ Sector: Healthcare Industry: Medical Devices
0.44% $2.27
America/New_York / 1 sep 2023 @ 15:57
FUNDAMENTALS | |
---|---|
MarketCap: | 17.88 mill |
EPS: | -5.70 |
P/E: | -0.398 |
Earnings Date: | Oct 30, 2023 |
SharesOutstanding: | 7.88 mill |
Avg Daily Volume: | 0.157 mill |
RATING 2023-09-14 |
---|
B |
Neutral |
RATINGS | ||
---|---|---|
Rating CashFlow: | Buy | |
Return On Equity: | Strong Sell | |
Return On Asset: | Strong Sell | |
DE: | Strong Buy | |
P/E: | Neutral | |
Price To Book: | Sell |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
1/22 | 2/22 | 3/22 | 4/22 | 1/23 | 2/23 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | ||||||
Debt |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE -0.398 | sector: PE -3.05 |
PE RATIO: COMPANY / INDUSTRY |
---|
0.00x |
Company: PE -0.398 | industry: PE 222.16 |
DISCOUNTED CASH FLOW VALUE |
---|
N/A |
N/A |
Expected Trading Range (DAY) |
---|
$ 2.24 - 2.28 ( +/- 0.97%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-09-05 | Desrochers Christine | Sell | 81 465 | Common Stock |
2023-09-05 | Augusti Mark A | Buy | 17 778 | Common Stock |
2023-09-05 | Augusti Mark A | Sell | 190 277 | Common Stock |
2023-09-05 | Bienkowski Carrie | Sell | 19 909 | Common Stock |
2023-09-05 | Fischetti Gary P | Sell | 10 470 | Common Stock |
INSIDER POWER |
---|
37.01 |
Last 95 transactions |
Buy: 11 050 651 | Sell: 1 697 895 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | $2.27 (0.44% ) |
Volume | 0.0071 mill |
Avg. Vol. | 0.157 mill |
% of Avg. Vol | 4.51 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
Conformis, Inc., a medical technology company, develops, manufactures, and sells patient-specific products and instrumentation. The company offers personalized knee replacement products, including iUni, iDuo, a custom-made partial knee replacement option for either unicompartmental or bicompartmental osteoarthritis of the knee; iTotal CR, a cruciate retaining total knee replacement product; iTotal PS, a posterior stabilized knee replacement product, as well as provides iTotal Identity and Identity Imprint knee replacement products. It also provides Conformis Hip System and Cordera hip replacement, which are hip replacement products; and iJigs, a personalized single-use patient-specific instrumentation. The company markets and sells its products to orthopedic surgeons, hospitals, and other medical facilities through sales force, independent sales representatives, and distributors in the United States, Germany, the United Kingdom, Austria, Ireland, Switzerland, Spain, Portugal, the Netherlands, Belgium, the Dutch Antilles, Suriname, Australia, the United Arab Emirates, the Sultanate of Oman, Italy, Poland, and other markets. Conformis, Inc. was incorporated in 2004 and is headquartered in Billerica, Massachusetts.